痛风和高尿酸血症治疗中几个有争议的问题
被引量:10
摘要
痛风是一种古老的疾病,早在数千年前的埃及木乃伊关节中已发现尿酸结晶,其发病机制和病理生理也都早已被详细阐明。
出处
《中华风湿病学杂志》
CAS
CSCD
北大核心
2012年第6期361-363,共3页
Chinese Journal of Rheumatology
参考文献19
-
1Becker MA, Chohan S. We can make gout management more successful now. Curr Opin Rheumatol, 2008, 20: 167-172.
-
2Hamburger M, Baraf HS, Adamson TC 3rd, et al. 2011 recom- mendations for the diagnosis and management of gout and hyper- urieemia. Postgrad Med, 2011, 123(6 Suppl 1): 3-36.
-
3Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford), 2007, 46: 1372-1374.
-
4Caspi D, Lubart E, Graft E, et al. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum, 2000, 43: 103-108.
-
5Louthrenoo W, Kasitanon N, Wichainun R, et al. Effect of minidose aspirin on renal function and renal uric acid handling in healthy young adults. J Clin Rheumatot, 2002, 8: 299-304.
-
6Segal R, Luhart E, Leibovitz A, et al. Early and late effects of low-dose aspirin on renal function in elderly patients. Am J Med, 2003, 115: 462-466.
-
7Baker JF, Schumacher HR. Update on gout and hyperuricemia. Int J Clin Praet, 2010, 64: 371-377.
-
8Huang HY, Appel LJ, Choi M J, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized Controlled trial. Arthritis Rheum, 2005, 52: 1843- 1847.
-
9Juraschek SP, Miller ER 3rd, Gelber'AC. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of ran- domized controlled trials. Arthritis Care Res (Hoboken), 2011, 63: 1295-1306.
-
10Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med, 2009, 169: 502-507.
二级参考文献5
-
1刘奉亭,梁继伟,孙桂滨,徐涛,姜峰.维生素C对尿酸测定的干扰及机制研究[J].华北煤炭医学院学报,2001,3(1):3-4. 被引量:5
-
2陈铭生,谢秀兰,徐晓萍.血清中内源性还原物对甘油三酯测定干扰的校正方法[J].上海医学检验杂志,1996,11(4):245-246. 被引量:2
-
3Sonntag O,Scholer A. Drug interference in clinical chemistry:recommendation of drugs and their concentrations to be used in drug interference studies[J]. Clin Biochem, 2001;38(Pt4) : 376-385.
-
4Langman LJ, Allen LC, Romaschin AD. Interference of IgM paraproteins in the Olympus AU800 uric acid assay[J]. Clin Biochem, 1998 ; 31 (7) :517-521.
-
5金鹤成.三酰甘油、尿酸试剂盒抗还原性干扰能力的评价[J].上海医学检验杂志,2001,16(2):111-112. 被引量:16
共引文献18
-
1杨玉然,田建军,张丽.胆红素对氧化酶法血糖测定的影响[J].医学检验与临床,2008,20(4):81-81.
-
2时兰春,王缚鲲,王仁杰,王江雁.各种胆红素对血清甘油三酯浓度测定的影响[J].实用医技杂志,2004,11(09A):1672-1674.
-
3李安久,张绪红,张秀香,季雪兰.亚甲蓝对肌酐酶法(POD系统)测定的影响[J].江西医学检验,2004,22(6):513-514. 被引量:2
-
4王缚鲲,王宪灵,安黎云,张宏,王薇,李玮.各种胆红素对氧化酶法测定血清尿酸浓度的影响[J].检验医学,2005,20(1):4-6. 被引量:3
-
5董辉苒,苗瑞睿,苗健伟.药物对常用临床检验指标的影响[J].首都医药,2006,13(20):37-38. 被引量:15
-
6高勇.血清直接、间接胆红素对氧化酶法测定三酰甘油浓度的影响分析[J].现代检验医学杂志,2006,21(6):45-47.
-
7高勇.血清直接、间接胆红素对氧化酶法测定甘油三脂浓度的影响分析[J].安徽医学,2007,28(1):69-71. 被引量:2
-
8杨玉然,田建军,张丽.总胆红素对血糖测定的影响[J].国际检验医学杂志,2009,30(6):604-604.
-
9郭洪晨,刘静.胆红素对临床检验结果的干扰及消除[J].检验医学与临床,2009,6(18):1573-1575. 被引量:17
-
10邓纪望,叶秋灵,唐旖娟.炎琥宁注射液对尿酸氧化酶法测定的干扰分析[J].检验医学与临床,2010,7(10):978-979. 被引量:1
同被引文献69
-
1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15755
-
2Khanna D, Khanna PP, Fitzgerald JD, et al. 2012 American College of Rbeumatology guidelines for management of gout. Part 2 : therapy and antiinflammatory prophylaxis of acute gouty arthritis [J]. Arthritis care Res (Hoboken), 2012, 64(10) : 1447-1461.
-
3Tojimbara T,Nakajima I,Yashima J,et al.Efficacy and safety of febuxostat,a novel nonpurine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in kidney transplant recipients[J].Transplantation proceedings,2014,46(2):511-513.
-
4Maekawa M,Tomida H,Aoki T,et al.Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure[J].Internal medicine,2014,53(6):609-612.
-
5Kang Y,Kim M J,Jang H N,et al.Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease[J].Journal of clinical pharmacy and therapeutics,2014,39(3):328-330.
-
6Sofue T,Inui M,Hara T,et al.Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients[J].Drug design,development and therapy,2014,8(5),245-253.
-
7Frazziano G,Al Ghouleh I,Baust J,et al.Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension:indications for a seminal role for mitochondrial Nox4[J].American journal of physiology Heart and circulatory physiology,2014,306(2):197-205.
-
8Hiramitsu S,Ishiguro Y,Matsuyama H,et al.Febuxostat(Feburic tablet)in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems[J].Clinical and experimental hypertension,2014,36(6):433-440.
-
9Tausche A K,Christoph M,Forkmann M,et al.As compared to allopurinol,urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout[J].Rheumatology international,2014,34(1):101-109.
-
10Hoy D G,Smith E,Cross M,et al.Reflecting on the global burden of musculoskeletal conditions:lessons learnt from the global burden of disease 2010 study and the next steps forward[J].Annals of the rheumatic diseases,2015,74(1):4-7.
引证文献10
-
1吴文虎,陈朝蔚,孙剑,裘敏蕾,邱卫东,戴琪萍.痛风颗粒联合双氯芬酸钠缓释片治疗急性痛风性关节炎临床疗效观察[J].上海中医药大学学报,2014,28(2):31-33. 被引量:10
-
2赵佳辉,桑鹏,王在东.土萆四妙汤配合非布司他治疗痛风和(或)高尿酸血症疗效性的系统评价[J].中国继续医学教育,2015,7(16):188-190. 被引量:5
-
3赵佳辉,李晶,王在东,秦亚冰,林雪莲.土萆四妙汤配合非布司他治疗痛风和(或)高尿酸血症安全性的系统评价[J].航空航天医学杂志,2015,26(8):997-999. 被引量:3
-
4宋旸,李存江.小剂量阿司匹林对脑卒中患者血尿酸水平影响的临床观察[J].北京医学,2016,38(5):421-423. 被引量:9
-
5温淼,杨波,于丹丹,张婧,杨中华,刘丽萍.阿司匹林联合阿托伐他汀和单独阿司匹林对缺血性卒中患者高尿酸血症发生率及卒中复发率影响的对比研究[J].中国全科医学,2016,19(30):3672-3674. 被引量:9
-
6邵俊华,袁放,陈春燕,周华俊,蒋飞,周宇一,郑勰,李琴,陈连珍.非布司他联合药用炭和维生素C治疗慢性痛风降尿酸效果分析[J].浙江医学,2017,39(11):925-927. 被引量:14
-
7卢小媚,蔡伟,李新,袁斌斌.心血管疾病患者住院期间并发急性痛风65例临床分析[J].江苏医药,2018,44(10):1121-1124. 被引量:1
-
8杨玉红,李晓涛,李金宝,李正秋.四妙散加减治疗阿司匹林诱发的急性痛风性关节炎湿热蕴结证的临床观察[J].中国临床医生杂志,2022,50(2):241-243. 被引量:12
-
9次旦卓嘎.STEMI患者服用替格瑞洛致痛风发作1例[J].西藏医药,2023,44(4).
-
10谢成钧.1例服用阿司匹林致痛风发作的案例分析[J].世界最新医学信息文摘,2017,17(68):184-184. 被引量:1
二级引证文献64
-
1曾飞.人性化护理在依达拉奉联合氯吡格雷治疗脑梗死护理中的应用及对患者NIHSS评分的影响[J].齐齐哈尔医学院学报,2018,39(16):1960-1962. 被引量:6
-
2黄玉华.双氯芬酸钠和别嘌呤醇联合用药治疗痛风性关节炎的临床疗效及不良反应分析[J].转化医学电子杂志,2015,2(7):106-107. 被引量:3
-
3汤景霞.双氯芬酸在治疗风湿性关节炎方面的临床疗效观察[J].中国伤残医学,2015,23(24):102-103.
-
4谷丽梅.非布司他治疗痛风伴高尿酸血症疗效观察[J].中国卫生标准管理,2016,7(7):106-107. 被引量:18
-
5张彦.非布司他与苯溴马隆治疗高尿酸血症的疗效对比分析[J].中国继续医学教育,2016,8(25):167-168. 被引量:2
-
6唐宇.非布司他联合痛风定胶囊对高尿酸血症患者炎性因子的影响[J].现代中西医结合杂志,2017,26(7):737-739. 被引量:28
-
7王晓娜.非布司他在高尿酸血症伴慢性肾病患者中的药代动力学及药效评价[J].中国医药指南,2017,15(12):58-59. 被引量:3
-
8曾主平,江卫群,陈碧.阿托伐他汀钙片和阿司匹林联合治疗社区老年2型糖尿病患者的可行性分析[J].中国实用医药,2017,12(17):131-133. 被引量:7
-
9付强.阿托伐他汀联合阿司匹林治疗缺血性脑卒中对颈动脉斑块及卒中复发的影响[J].中国药业,2017,26(18):29-31. 被引量:11
-
10唐运洪.非布司他在高尿酸血症合并慢性肾功能不全患者中的应用效果与安全性[J].中国现代药物应用,2017,11(20):124-125. 被引量:8
-
1刘枫,刘忠喜,赵凤国.浅析血尿酸与冠心病[J].医学信息(下旬刊),2009(9):263-263. 被引量:2
-
2黄云芳.痛风,疼时再看就晚了[J].养生保健指南,2015,0(3):48-48.
-
3肥胖与抗生素有关木乃伊或能治疗[J].大众健康,2012(5):14-14.
-
4田洪涛.痛风,不能因噎废食[J].医药食疗保健,2016,0(7):34-34.
-
5对木乃伊“体检”发现超三成有动脉硬化迹象[J].科学养生,2013(6):8-8.
-
6薛佳,张伟,孙婧,曹娟.高尿酸血症与颈动脉粥样硬化的关系[J].中国循证心血管医学杂志,2015,7(5):684-686. 被引量:12
-
7毕玲爱,纪培志.肝硬变腹水的低钠血症治疗[J].临床荟萃,1998,13(16):738-739. 被引量:6
-
8郑著家.41例肝硬化腹水并发低钠血症治疗体会[J].齐齐哈尔医学院学报,2015,36(9):1317-1318. 被引量:1
-
9梁文京,邱金玉.别嘌呤醇在急性心肌梗死合并高尿酸血症治疗中的应用效果分析[J].齐齐哈尔医学院学报,2015,36(19):2859-2860.
-
10简岩.人类有信心战胜艾滋病[J].百科知识,2011(23):1-1.